Legato Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Legato Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$225K	Buy
2024 Q1	–	Sell
2023 Q4	$206K	Buy
2018 Q1	–	Sell
2017 Q4	$886K	Sell
2017 Q3	$1.27M	Buy
2017 Q2	$223K	Buy